First italian consensus statement on diagnosis, prevention and treatment of cardiovascular complications in HIV-infected patients in the HAART era (2006)

被引:13
作者
Carosi, G.
Quiros-Roldan, E.
Torti, C.
Antinori, A.
Bevilacqua, M.
Bonadonna, R. C.
Bonfanti, P.
Castagna, A.
Cauda, R.
d'Arminio-Monforte, A.
Di Gregorio, P.
Di Perri, G.
Esposito, R.
Fatuzzo, F.
Gervasoni, C.
Giannattasio, C.
Guaraldi, G.
Lazzarin, A.
Lo Caputo, S.
Maggi, P.
Mazzotta, F.
Moroni, M.
Prestileo, T.
Ranieri, R.
Rizzardini, G.
Russo, R.
Galli, M.
机构
[1] Univ Brescia, Clin Malattie Infett & Trop, I-25123 Brescia, Italy
[2] Ist Nazl Malattie Infett, Rome, Italy
[3] Osped L Sacco, Unita Endorcinol, Milan, Italy
[4] Univ Verona, Dipartimento Sci Biomed & Chirurg, I-37100 Verona, Italy
[5] Osped L Sacco, Div Malattie Infett, Milan, Italy
[6] IRCCS, Milan, Italy
[7] Univ Cattolica Sacro Cuore, Clin Malattie Infett, Rome, Italy
[8] Azienda Ospedallera S Paolo, Clin Malattie Infett & Trop, Milan, Italy
[9] Spedale Cannizzaro, UO Malattie Infett, Catania, Italy
[10] Univ Turin, Clin Malattie Infett, Turin, Italy
[11] Univ Modena, Clin Malattie Infett & Trop, I-41100 Modena, Italy
[12] Univ Ferrarotto S Bambino, Catania, Italy
[13] Univ Milan, Clin Malattie Infett & Trop, Milan, Italy
[14] Osped S Gerardo Nuovo, Clin Med 9, Monza, Italy
[15] Osped SM Annunziata, UO Malattie Infett, Florence, Italy
[16] Policlin Bari, Clin Malattie Infett, Bari, Italy
[17] Osped Casa Sole, UO Malattie Infett, Palermo, Italy
[18] Univ Catania, Clin Malattie Infett, Catania, Italy
关键词
D O I
10.1007/s15010-007-6295-5
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The present document contains recommendations for assessment, prevention and treatment of cardiovascular risk for HIV-infected patients. All recommendations were graded according to the strength and quality of the evidence and were voted on by 73 members of the Italian Cardiovascular Risk Guidelines Working Group which includes both experts in HIV/AIDS care and in cardiovascular and metabolic medicine. Since antiretroviral drug exposure represents only one risk factor, continued emphasis on an integrated management is given. This should include prevention and treatment of known cardiovascular risk factors (such as dyslipidaemia, diabetes, insulin resistance, healthy diet, physical activity, avoidance of smoking), but also rational switch of antiretroviral drugs. A rational switch strategy should consider both metabolic and anthropometric disturbances and effectiveness of antiretroviral regimens.
引用
收藏
页码:134 / 142
页数:9
相关论文
共 35 条
[1]   No association between hepatitis C virus seropositivity and acute myocardial infarction [J].
Arcari, Christine M. ;
Nelson, Kenrad E. ;
Netski, Dale M. ;
Nieto, F. Javier ;
Gaydos, Charlotte A. .
CLINICAL INFECTIOUS DISEASES, 2006, 43 (06) :E53-E56
[2]   Cumulative exposure to nucleoside analogue reverse transcriptase inhibitors is associated with insulin resistance markers in the multicenter AIDS cohort study [J].
Brown, TT ;
Li, XH ;
Cole, SR ;
Kingsley, LA ;
Palella, FJ ;
Riddler, SA ;
Chmiel, JS ;
Visscher, BR ;
Margolick, JB ;
Dobs, AS .
AIDS, 2005, 19 (13) :1375-1383
[3]   Key questions in antiretroviral therapy: Italian Consensus Workshop (2005) [J].
Carosi, G. ;
Torti, C. ;
Andreoni, M. ;
Angarano, G. ;
Antinori, A. ;
Bonora, S. ;
Borderi, M. ;
Castagna, A. ;
Castelli, F. ;
Cauda, R. ;
Chiodo, F. ;
D'arminio-Monforte, A. ;
De Luca, A. ;
Di Perri, G. ;
Dianzani, F. ;
Filice, G. ;
Galli, M. ;
Lazzarin, A. ;
Maggiolo, F. ;
Maserati, R. ;
Mazzotta, F. ;
Moroni, M. ;
Perno, C. F. ;
Vullo, V. .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2006, 57 (06) :1055-1064
[4]   No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial [J].
Carr, A ;
Workman, C ;
Carey, D ;
Rogers, G ;
Martin, A ;
Baker, D ;
Wand, H ;
Law, M ;
Samaras, K ;
Emery, S ;
Cooper, DA .
LANCET, 2004, 363 (9407) :429-438
[5]  
CARR A, 2006, 13 C RETR OPP INF 5
[6]   Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure [J].
Chobanian, AV ;
Bakris, GL ;
Black, HR ;
Cushman, WC ;
Green, LA ;
Izzo, JL ;
Jones, DW ;
Materson, BJ ;
Oparil, S ;
Wright, JT ;
Roccella, EJ .
HYPERTENSION, 2003, 42 (06) :1206-1252
[7]   Executive summary of the Third Report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) [J].
Cleeman, JI ;
Grundy, SM ;
Becker, D ;
Clark, LT ;
Cooper, RS ;
Denke, MA ;
Howard, WJ ;
Hunninghake, DB ;
Illingworth, DR ;
Luepker, RV ;
McBride, P ;
McKenney, JM ;
Pasternak, RC ;
Stone, NJ ;
Van Horn, L ;
Brewer, HB ;
Ernst, ND ;
Gordon, D ;
Levy, D ;
Rifkind, B ;
Rossouw, JE ;
Savage, P ;
Haffner, SM ;
Orloff, DG ;
Proschan, MA ;
Schwartz, JS ;
Sempos, CT ;
Shero, ST ;
Murray, EZ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (19) :2486-2497
[8]   Antiretroviral medications associated with elevated blood pressure among patients receiving highly active antiretroviral therapy [J].
Crane, Heidi M. ;
Van Rompaey, Stephen E. ;
Kitahata, Mari M. .
AIDS, 2006, 20 (07) :1019-1026
[9]  
Duong M, 2001, J ACQ IMMUN DEF SYND, V27, P245, DOI 10.1097/00126334-200107010-00005
[10]   Combination antiretroviral therapy and the risk of myocardial infarction [J].
Friis-Moller, N ;
Sabin, CA ;
Weber, R ;
Monforte, AD ;
El-Sadr, WM ;
Reiss, P ;
Thiébaut, R ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Lundgren, JD ;
Lundgren, JD ;
Weber, R ;
Monteforte, AD ;
Bartsch, G ;
Reiss, P ;
Dabis, F ;
Morfeldt, L ;
De Wit, S ;
Pradier, C ;
Calvo, G ;
Law, MG ;
Kirk, O ;
Phillips, AN ;
Houyez, F ;
Loeliger, E ;
Tressler, R ;
Weller, I ;
Friis-Moller, N ;
Sabin, CA ;
Sjol, A ;
Lundgren, JD ;
Sawitz, A ;
Rickenbach, M ;
Pezzotti, P ;
Krum, E ;
Meester, R ;
Lavignolle, V ;
Sundström, A ;
Poll, B ;
Fontas, E ;
Torres, F ;
Petoumenos, K ;
Kjær, J ;
Hammer, S ;
Neaton, J .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 349 (21) :1993-2003